[go: up one dir, main page]

NO20050801L - Prodrug av protonpumpe inhibitorer - Google Patents

Prodrug av protonpumpe inhibitorer

Info

Publication number
NO20050801L
NO20050801L NO20050801A NO20050801A NO20050801L NO 20050801 L NO20050801 L NO 20050801L NO 20050801 A NO20050801 A NO 20050801A NO 20050801 A NO20050801 A NO 20050801A NO 20050801 L NO20050801 L NO 20050801L
Authority
NO
Norway
Prior art keywords
proton pump
pump inhibitors
prodrug
prodrugs
bioavailability
Prior art date
Application number
NO20050801A
Other languages
English (en)
Norwegian (no)
Inventor
George Sachs
Jai Moo Shin
Michael E Garst
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO20050801L publication Critical patent/NO20050801L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO20050801A 2002-07-19 2005-02-15 Prodrug av protonpumpe inhibitorer NO20050801L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39745902P 2002-07-19 2002-07-19
PCT/US2003/022419 WO2004009583A2 (fr) 2002-07-19 2003-07-15 Promedicaments des inhibiteurs de la pompe a protons

Publications (1)

Publication Number Publication Date
NO20050801L true NO20050801L (no) 2005-02-15

Family

ID=30771064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050801A NO20050801L (no) 2002-07-19 2005-02-15 Prodrug av protonpumpe inhibitorer

Country Status (22)

Country Link
US (3) US6897227B2 (fr)
EP (1) EP1556371B1 (fr)
JP (1) JP4463103B2 (fr)
KR (2) KR100788778B1 (fr)
AT (1) ATE323695T1 (fr)
AU (1) AU2003259154B2 (fr)
BR (1) BR0312802A (fr)
CA (1) CA2492718C (fr)
CO (1) CO5690576A2 (fr)
DE (1) DE60304726T2 (fr)
DK (1) DK1556371T3 (fr)
ES (1) ES2263028T3 (fr)
IL (1) IL166371A0 (fr)
MX (1) MXPA05000657A (fr)
NO (1) NO20050801L (fr)
NZ (1) NZ538221A (fr)
PL (1) PL375255A1 (fr)
PT (1) PT1556371E (fr)
RU (1) RU2292342C2 (fr)
TW (1) TW200502231A (fr)
WO (1) WO2004009583A2 (fr)
ZA (1) ZA200501116B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
WO2004012659A2 (fr) * 2002-08-01 2004-02-12 Nitromed, Inc. Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation
PL379542A1 (pl) * 2003-07-15 2006-10-02 Allergan, Inc. Sposób wytwarzania izomerycznie czystych proleków inhibitorów pompy protonowej
WO2005039640A1 (fr) * 2003-10-03 2005-05-06 Allergan Inc. Compositions contenant des peptides en trefle et/ou des mucoadhesifs et des promedicaments d'un inhibiteur de pompe a proton
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
CA2556756A1 (fr) * 2004-02-18 2005-09-09 Allergan, Inc. Methodes et compositions d'administration de promedicaments d'inhibiteurs de la pompe a protons
JP2007523164A (ja) * 2004-02-18 2007-08-16 アラーガン、インコーポレイテッド プロトンポンプインヒビターに関連する化合物の静脈内投与のための方法および組成物
EP1722794A1 (fr) * 2004-03-11 2006-11-22 Allergan, Inc. Methodes et compositions pour le traitement de troubles associes a une secretion d'acide gastrique
ATE437869T1 (de) 2004-04-28 2009-08-15 Hetero Drugs Ltd Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
WO2007073301A1 (fr) * 2005-12-23 2007-06-28 Astrazeneca Ab Derives du benzoimidazole en tant que promedicaments d'inhibiteurs de la pompe a protons
US20070265311A1 (en) * 2006-01-10 2007-11-15 Rubino Mark P Therapeutic Salt Compositions and Methods
AU2007248949B2 (en) * 2006-05-09 2010-04-08 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
US20070293543A1 (en) * 2006-06-19 2007-12-20 Edward Lee THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z
WO2008036201A1 (fr) * 2006-09-19 2008-03-27 Alevium Pharmaceuticals, Inc. Promédicaments d'inhibiteurs de pompes à protons comprenant le groupe fonctionnel 1h-imidazo[4,5-b] pyridine
WO2008036211A1 (fr) * 2006-09-19 2008-03-27 Alevium Pharmaceuticals, Inc. Promédicaments d'inhibiteurs de pompes à protons comprenant le groupe fonctionnel (1h-pyrrol-1-yl)-1h-benzimidazole
WO2009044976A1 (fr) * 2007-10-05 2009-04-09 Lg Electronics Inc. Dispositif d'affichage à plasma
KR20090035195A (ko) * 2007-10-05 2009-04-09 엘지전자 주식회사 플라즈마 디스플레이 장치
KR100895333B1 (ko) * 2007-11-01 2009-05-07 엘지전자 주식회사 플라즈마 디스플레이 패널의 구동 방법 및 그를 이용한플라즈마 디스플레이 장치
US8927559B2 (en) 2010-10-11 2015-01-06 Merck Sharp & Dohme Corp. Quinazolinone-type compounds as CRTH2 antagonists
WO2012087872A1 (fr) 2010-12-23 2012-06-28 Merck Sharp & Dohme Corp. Quinoléines et aza-quinoléines en tant que modulateurs de l'activité du récepteur crth2
AU2011349524B2 (en) 2010-12-23 2016-06-02 Merck Sharp & Dohme Corp. Quinoxalines and aza-quinoxalines as CRTH2 receptor modulators
CA2973370A1 (fr) * 2015-01-09 2016-07-14 The Regents Of The University Of California Compositions et methodes de traitement d'infections gastro-intestinales
CN108997177A (zh) * 2018-09-04 2018-12-14 邵阳学院 一种微波促进n-苯磺酰基硝基苯胺类化合物合成的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US430042A (en) * 1890-06-10 Valve
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
IL76839A (en) 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
US4758597A (en) 1987-05-15 1988-07-19 University Patents, Inc. Carenadiol and derivatives
US4965269A (en) 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5045522A (en) 1990-03-27 1991-09-03 Phillips Petroleum Company Absorption composition comprising zinc titanate for removal of hydrogen sulfide from fluid streams
AU649456B2 (en) 1990-06-20 1994-05-26 Astra Aktiebolag Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
RU2139286C1 (ru) * 1994-06-10 1999-10-10 Бык Гульден Ломберг Хемише Фабрик Гмбх Замещенные арилалкилтиоалкилтиопиридины для борьбы с бактериями helicobacter
US5708017A (en) 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6093734A (en) 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
HRP20010106A2 (en) * 1998-08-10 2002-02-28 Partnership Of Michael E Garst Prodrugs of proton pump inhibitors
RU2244712C2 (ru) * 1998-08-12 2005-01-20 Гайлид Сайенсиз, Инк. Способ получения 1,3-оксатиоланового нуклеозида, способ получения производного 1,3-оксатиоланил-5-она
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6599167B2 (en) 2000-09-27 2003-07-29 Glenn Waltz Game call holder and amplifying device
WO2002030920A1 (fr) 2000-10-12 2002-04-18 Takeda Chemical Industries, Ltd. Composes derives de benzimidazole, leur procede de production et leur utilisation

Also Published As

Publication number Publication date
KR20050047078A (ko) 2005-05-19
AU2003259154B2 (en) 2006-12-07
KR100822981B1 (ko) 2008-04-16
DE60304726D1 (de) 2006-05-24
EP1556371A2 (fr) 2005-07-27
KR100788778B1 (ko) 2007-12-27
RU2005105564A (ru) 2005-10-10
AU2003259154C1 (en) 2004-02-09
US6897227B2 (en) 2005-05-24
BR0312802A (pt) 2005-04-19
NZ538221A (en) 2006-11-30
PT1556371E (pt) 2006-09-29
WO2004009583A3 (fr) 2004-03-18
IL166371A0 (en) 2006-01-16
WO2004009583A2 (fr) 2004-01-29
ES2263028T3 (es) 2006-12-01
CA2492718C (fr) 2010-12-21
KR20070005029A (ko) 2007-01-09
JP4463103B2 (ja) 2010-05-12
RU2292342C2 (ru) 2007-01-27
EP1556371B1 (fr) 2006-04-19
ATE323695T1 (de) 2006-05-15
DE60304726T2 (de) 2007-08-09
PL375255A1 (en) 2005-11-28
US20040102484A1 (en) 2004-05-27
JP2005536519A (ja) 2005-12-02
HK1079207A1 (en) 2006-03-31
CO5690576A2 (es) 2006-10-31
MXPA05000657A (es) 2005-08-19
US20050143423A1 (en) 2005-06-30
CA2492718A1 (fr) 2004-01-29
AU2003259154A1 (en) 2004-02-09
ZA200501116B (en) 2006-11-29
TW200502231A (en) 2005-01-16
DK1556371T3 (da) 2006-08-21
US20050182101A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
NO20050801L (no) Prodrug av protonpumpe inhibitorer
NO20071095L (no) Hittil ukjente tiofenderivater
NO20055135L (no) Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
NO20091395L (no) Nye tiofenderivater
NO20082793L (no) Nye tiofenderivater
NO20076648L (no) Novel thiophene derivatives
NO20063925L (no) Indazolderivater som inhibitorer av hormonsensitiv lipase
ATE324371T1 (de) N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
WO2005110410A3 (fr) Inhibiteurs de kinases en tant qu'agents therapeutiques
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
NO20070557L (no) Ftalazinderivater som PARP-inhibitorer
NO20070445L (no) Pyrimidinderivater.
NO20054848L (no) Substituerte p-diaminobenzenderivater
DK1784404T3 (da) Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
DK2263674T3 (da) 10,10-Dialkyl-prostansyrederivater som midler til sænkning af intraokulært tryk
NO20080554L (no) Pyrazolonderivater
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DE60027144D1 (de) Hydroxamsäure-derivate
EP1650194A4 (fr) Inhibiteur de la proteine kinase
NO20084543L (no) Benzimidazolderivater
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
WO2004067703A3 (fr) Antagonistes 5ht7 et agonistes inverses

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application